Introduction
Gestational diabetes mellitus (GDM) is defined as glucose intolerance developed during pregnancy.
1 As with type 2 diabetes mellitus (T2DM), the incidence of GDM is growing; GDM currently affects an estimated 5-10% of pregnancies in the United States, with approximately 250,000 new cases each year.
2 Not only has there been a steady increase in the prevalence of GDM over the past 20 years, but the rising national trends of advanced maternal age, obesity, and decreased physical activity will contribute to a further increase in the prevalence of GDM in years to come. 3 The diagnosis of GDM bears associated short-term and long-term risks for both the infant and mother. The correlation between GDM and macrosomia, neonatal hypoglycemia, birth trauma, and subsequent overweight in the offspring has been well established. 4 For the mother, GDM is associated with increased risk of hypertensive disorders, cesarean delivery, and other perinatal complications.
5 Furthermore, 30% of women with GDM remain glucose intolerant after delivery, and over half ultimately receive the diagnosis of overt diabetes. 6 The risks of T2DM in pregnancies subsequent to an index pregnancy with GDM are amplified beyond those incurred by GDM alone.
7-9
The first step in long-term risk management of women with GDM is postpartum glucose tolerance testing. Groups such as the American College of Obstetricians and Gynecologists (ACOG) and the American Diabetes Association (ADA) recommend that women with GDM receive care 6-12 weeks after delivery to assess blood pressure, body mass index, and metabolic profile, in addition to routine postpartum concerns (Table 1) . Women are additionally recommended to visit their primary care provider (PCP) within a year of delivery; PCPs may perform further metabolic testing, recommend pharmacologic therapy, and utilize lifestyle modalities to promote weight loss, which has been shown to reduce the onset of diabetes, as demonstrated in the Diabetes Prevention Program.
10-13
Despite these recommendations, data reveal that <50% of women with GDM partake in any form of postpartum glucose testing.
14-18 Our goal is to use a public health and health services perspective to discuss barriers to optimal postpartum care for women with GDM, review evidence-based interventions, and offer recommendations for a multilevel approach for serving this important and growing population.
Barriers to diabetes postpartum care
Receipt of appropriate postpartum glucose testing is contingent upon returning for postpartum care. Extensive literature explores common barriers to postpartum follow-up; such barriers include out-of-pocket costs, lack of health insurance, appointment wait times, child care availability, transportation costs, demanding work schedules, and lack of supported parental leave. [19] [20] [21] Additional barriers specific to completing the postpartum oral glucose tolerance test (OGTT) can be divided into patient characteristics and beliefs, inadequate provider training, and ineffective system-level practices, which are discussed below.
Several studies sought to identify individual characteristics associated with postpartum appointment attendance and OGTT completion in women with GDM. Patients who are Asian, older, nulliparous, or have medicationcontrolled GDM are more likely to return for testing. 14, 15, 22 Risk factors for poor follow-up include Latina ethnicity, public insurance, less education, and lower health literacy. 14, 15, 23 Low health literacy has a well-studied association with inadequate health service utilization, and in this particular population, limited literacy/numeracy could limit T2DM risk estimation or result in confusion regarding instructions.
24
Among women who report understanding their future T2DM risk but do not complete OGTT, many express anxiety about receiving a T2DM diagnosis, citing fears of diabetes complications and needing lifelong insulin. 20, 21, 25 From a provider perspective, ACOG best practices include counseling women with GDM about their higher lifetime risk of cardiometabolic disease, as well as ensuring that these women undergo postpartum glucose screening. 19 The ADA recommends women with a history of GDM receive education about lifestyle modification.
1 While the recommendations are well established, the literature suggests room for improvement in provider knowledge and implementation. One study, for example, showed the minority of obstetricians/gynecologists knew that >40% of women with GDM will progress to T2DM within 10 years.
26
This work also showed that exercise counseling and nutrition referrals were low for both obstetrician/gynecologists and certified nurse-midwives. 26, 27 Limited access to care and inadequate obstetric-primary care transitions pose system-level barriers to long-term diabetes prevention and management. In many states, Medicaid coverage for the mother extends to only 60 days postpartum.
28 Subsequent care may require women to pay out of pocket, which poses a cost burden that likely deters mothers from pursuing long-term health care. While new mothers are encouraged to seek health care through systems such as Affordable Care Act plans, enrollment can be challenging and may not occur in a timely manner. Thus, for women in underserved communities in particular, many of whom may not have physician contact prior to or between pregnancies, it can be especially difficult to focus on primary prevention. Martinez. Postpartum care after GDM. Am J Obstet Gynecol 2017.
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